Device Trial Radar · NCT07660185
A Clinical Study of X-Clip Mitral Valve Clip System and Steerable Guide System for Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation
Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Mar 1, 2027
Primary completion
May 31, 2028
Study completion Aug 31, 2032
Sponsor
- Lead sponsor
- Shenzhen Lifevalve Medical Scientific Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Lifetech Scientific (Shenzhen) Co., Ltd.
- First posted
- Jun 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Shenzhen Lifevalve Medical Scientific Co., Ltd. has developed a new X-Clip Mitral Valve Clip System and its compatible Steerable Guide System, aiming to provide transcatheter mitral valve repair for patients with degenerative mitral regurgitation. The two systems have completed all preclinical tests, including design verification tests, biological evaluation, and animal studies. All the test results confirmed that the systems met relevant design requirements. A First-in-Man clinical study was conducted in China in 2023, involving 11 patients. The study provides initial evidence that the X-Clip Mitral Valve Clip System and Steerable Guide System demonstrate favourable safety and efficacy in the treatment of mitral regurgitation in the Chinese population. The device is currently undergoing a pivotal clinical trial in China. This study is a clinical study aimed to evaluate the safety and performance of the X-Clip Mitral Valve Clip System and Steerable Guide System in European population.
Conditions
- Transcatheter Mitral Valve Repair of Degenerative Mitral Regurgitation
Interventions
X-Clip Treatment for Degenerative Mitral RegurgitationDevice
Adult patients with moderate-to-severe or severe primary/degenerative mitral regurgitation (MR ≥3+) undergoing transcatheter mitral valve repair using the X-Clip Mitral Valve Clip System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of major adverse events (MAEs) within 30 days after operationTime frame: At pre-discharge, 30 days ± 7 days post-procedure
1 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Hospital Clinic de Barcelona
Barcelona, Spain
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.